Dobutamine Hydrochloride

Overview

Dobutamine Hydrochloride is a sympathomimetic drug used to treat heart failure and cardiogenic shock by increasing myocardial contractility. It works by stimulating beta-1 adrenergic receptors, resulting in improved cardiac output.

API suppliers (11)

Suppliers of Dobutamine Hydrochloride evidenced by a US FDA Type II Drug Master File or an EU Certificate of Suitability (CEP). Sources: FDA DMF list, EDQM certification database.

• RECORDATI INDUSTRIA CHIMICA E FARMACEUTICA SPAItaly1 active DMF GMP on record
• SIEGFRIED PHARMACHEMIKALIEN MINDEN GMBHGermany1 active DMF GMP on record
• Aragen Life SciencesIndia1 active DMF
• CHEMWERTH INCFrance1 active DMF
• CHEMSYN SCIENCE LABORATORIES
• IROTEC LABORATORIES
• EGIS PHARMACEUTICALS PRIVATE LTD GMP on record
• HUHTAMAKI OY LEIRAS PHARMACEUTICALS
• Abbott LaboratoriesUSA GMP on record
• RAYLO CHEMICALS
• SUMIKA FINE CHEMICALS CO LTD

EU CEP holders (5)

Companies holding a valid EU Certificate of Suitability (CEP) for Dobutamine Hydrochloride, from the EDQM certification database. A CEP holder is a documented EU-market source of the substance — not necessarily the manufacturer — and these are not yet profiled in our directory.

Therapeutic areas